Stanley Fayn

8PUBLICATIONS
64CO-AUTHORS
Molecular targetsPredictive and prognostic markersGlycoconjugatesAnimal physiological ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 09, 2026
Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.

|May 25, 2026
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway.

|Dec 15, 2025
Multimodal Approach for Identification and Validation of Hepatocellular Carcinoma Targets for Radiotheranostics.

Philip Homan, Joon-Yong Chung, Woonghee Lee

|Oct 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PET.

Stanley Fayn, Woonghee Lee, Falguni Basuli

|Sep 26, 2025
Biodistribution-Driven Discovery Identifies a Glycosidase-Cleavable Linker to Reprogram Radiotheranostics.

Woonghee Lee, Sai Reddy Doda, Kwamena E Baidoo

|Feb 18, 2025
Generation of Site-Specifically Labeled Affinity Reagents via Use of a Self-Labeling Single Domain Antibody.

Stanley Fayn, Swarnali Roy, Chino C Cabalteja

Pageof 2

Frequent Collaborators

6 joint publications

Freddy E Escorcia

6 joint publications

Woonghee Lee

5 joint publications

Divya Nambiar

4 joint publications

Hima Makala